HOME CARE
Private equity vs strategic buyer: which is right for your home care agency?
A strategic buyer runs home care itself, usually pays mostly cash, and folds your agency into its own systems. Private equity buys to sell again, and for a small agency that usually means a PE-backed home care platform that pays most of the price in cash and asks you to roll part into its equity. Choose a strategic for a clean exit, a platform if you want to stay for a second payday.
Find out who is buying agencies like yours →How rollover equity works →
By Akim Guennani, Founder · Updated November 2026
37%
2025 home health and hospice deals involving PE firms or their portfolio companies
4.7x
Median EBITDA multiple, home-based care deals under $10M enterprise value
What is the difference between a strategic buyer and private equity in home care?
A strategic buyer operates home care and buys your agency to add clients, caregivers, referral sources and markets to a business it plans to keep. A private equity fund buys agencies as an investment it expects to sell, usually within three to six years. In home care the two overlap, because many of the operators buying small agencies are themselves owned by a fund: an operator with a sponsor's capital and a sponsor's exit clock.
There are five kinds of acquirer you will meet, and the label matters less than who funds the deal and what they plan to do with your agency in five years.
- Public strategics
- Addus HomeCare, Aveanna, BrightSpring and Pennant, plus UnitedHealth's Optum, which bought Amedisys for about $3.3 billion. They pay from cash and credit lines and keep what they buy. Enhabit was in this group until Kinderhook Industries, a private equity firm, took it private in May 2026, a reminder that a strategic's owner can change too.
- PE-backed platforms buying add-ons
- Home care companies owned by a fund, such as Help at Home (bought by Centerbridge and Vistria in 2020), which tied for the most home health and hospice deals in 2025 with four, or Avid Health at Home, which completed its eighth tuck-in in August 2026. They usually ask you to roll part of the price into their equity.
- PE funds buying a new platform
- A fund buying its first home care company. Most are large, like TEAM Services at about $3 billion, but a fund can also start small: Havencrest formed Avid Health at Home in 2023 by buying one Chicago-area non-medical home care agency, For Papa's Sake Home Care.
- Regional private operators
- Family-owned or founder-led agencies expanding into the next county or state. Often the simplest buyer, sometimes a competitor you already know.
- Independent sponsors and search funds
- Individuals or small teams who raise equity deal by deal. Their financing is not committed until they find you, so certainty of closing is the first thing to test.
Do strategics or private equity pay more for a home care agency?
Neither pays more as a rule. They justify the price in different ways, and the higher bid usually comes from whichever buyer wants your market most.
A strategic already serving your county can close your office, move billing and payroll onto its own staff, and run your schedulers on its system. Those savings let it pay a higher multiple of your EBITDA while paying a lower multiple of what your agency will earn inside its company. A strategic with no overlap in your market has fewer savings to pay you with.
A PE-backed platform prices on the gap between small and large company multiples. Scope Research puts the median for home-based care deals under $10 million of enterprise value at 4.7 times EBITDA. At the other end, Bloomberg reported that General Atlantic paid about 10 times EBITDA for TEAM Services in 2026. A platform that buys agencies near the first number and expects to sell near the second can bid hard for a clean, growing agency. That same gap is why it asks you to roll equity: much of its return arrives at the next sale.
What happens to your caregivers, office and brand after closing?
Caregivers and nurses almost always stay, because they are what the buyer is paying for. The changes land on the back office: payroll, billing, EMR and scheduling software, HR and accounting usually move to the buyer's systems within months, whoever buys you.
The difference is in how far integration goes. When BrightSpring bought home health and hospice locations divested in the UnitedHealth and Amedisys deal in 2025, it said it would retain all employees, and its CEO said it planned to apply some of its payer contracts, IT and people practices to them. Pennant runs each operation under local clinical and operational leaders while its Service Center handles accounting, payroll, HR, IT and legal. A strategic in your own market is the buyer most likely to merge offices and retire your name. A platform entering a new state often keeps your local brand and leadership, at least until it has enough agencies there to consolidate.
Should you take rollover equity from a PE-backed platform?
Take it if you could live with losing the rolled amount and you believe in the platform more than in your own agency. Your rolled stake no longer depends on your agency; it depends on the platform's growth, its debt and the multiple at its next sale, none of which you control.
Rollover is how sellers to PE get a second bite of the apple, and platforms do change hands: Wellspring bought Help at Home in 2015, sold it to Centerbridge and Vistria in 2020 while keeping a minority stake, and its new owners were reported in December 2023 to be weighing a sale that could value it at $3 billion or more. The worked example below shows how the same rollover can nearly triple or go to zero. Your M&A attorney and CPA should review the equity documents and the tax structure before you sign a letter of intent.
Which buyer should you choose?
Start with what you want the day after closing, then pick the buyer type. Owners who want to retire and take the most cash now usually do best with a strategic or a regional operator paying cash. Owners who want to keep running the agency and believe home care will keep consolidating usually do best with a PE-backed platform and a rollover. Owners whose priority is their staff and name should ask each buyer what it did with the last three agencies it bought, then call those owners.
Recent home care deals by buyer type
Most home care deals are small and never disclose a price. LevinPro HC counted 110 home health and hospice deals announced in 2025, mostly smaller tuck-ins. PE firms or their portfolio companies were in about 37 percent of them; strategic and regional operators did the majority. So expect to hear from both kinds of buyer. The larger deals below are public because a listed company had to report them, and they show how each buyer type pays and what it buys.
| Buyer | Type | What it bought | Price and structure (as disclosed) |
|---|---|---|---|
| Addus HomeCare | Public strategic | Gentiva's personal care operations in 7 states, about $280M of annualized revenue; closed December 2024 | $350M cash; part equity, part asset purchase; funded with a $233M revolver draw, cash and stock offering proceeds |
| Aveanna Healthcare | Public strategic | Family First Homecare, pediatric private duty nursing, 27 locations in 7 states; closed June 2026 | $175.5M cash, funded from cash on hand |
| Optum (UnitedHealth) | Payer-owned strategic | Amedisys, home health and hospice; closed August 2025 | $101 per share in cash, about $3.3B; 164 locations in 19 states sold off to settle with the DOJ |
| Pennant Group | Public strategic | 54 of those divested home health and hospice locations in Tennessee, Georgia and Alabama; October 2025 | $146.5M |
| Avid Health at Home (Havencrest) | PE-backed platform add-on | Tech Medical Home Care Services in Kentucky and Ohio; August 2026, Avid's eighth tuck-in | Not disclosed |
| Centerbridge and Vistria | PE buying from PE | Help at Home, 155 locations in 13 states; 2020 | Not disclosed; seller Wellspring kept a minority stake |
| General Atlantic | PE fund, new platform | TEAM Services, home care and household employment services, bought from Alpine Investors; 2026 | About $3B including debt, about 10x EBITDA (Bloomberg) |
Side by side: strategic vs PE-backed platform
These are typical patterns, not rules. A specific buyer's answers to the questions further down matter more than its category.
| What matters to you | Strategic operator | PE-backed platform (add-on) |
|---|---|---|
| How it justifies the price | Cost savings from merging your back office and office into its own | Buying at a small-agency multiple and selling the larger platform at a higher one |
| Structure | Mostly cash at closing; earnout if there is a valuation gap | Cash plus rollover equity; sometimes an earnout |
| Speed and certainty | Funded from balance sheet; very large deals can face long antitrust reviews | Experienced deal team and committed credit lines; lender sign-off adds a step |
| Diligence | Internal compliance, clinical and accounting teams | Quality of earnings report plus lender and legal diligence |
| Staff | Caregivers kept; duplicate office roles cut if it already serves your area | Caregivers kept; office roles consolidated as the platform adds agencies nearby |
| EMR, scheduling and payroll | Moved to its systems | Moved to platform systems, sometimes after a transition period |
| Brand | Often retired in markets it already serves | Often kept at first, especially in a new state |
| Your role after closing | Usually a transition period, then out | Often stay as local or regional leader, tied to your equity |
| Second bite of the apple | None unless you receive stock | Through rollover, when the platform is sold |
| In 3 to 6 years | Your agency stays inside the same company | The platform is sold, often to a larger fund or a strategic, and you face a new owner |
Worked example: 25 percent rollover into a PE-backed platform
All figures are illustrative and simplified: no taxes, fees, escrow, working capital adjustments, preferred returns or dilution from later capital raises.
Your agency has $1,000,000 of adjusted EBITDA. A platform offers 5 times, or $5,000,000, with 25 percent rolled. You take $3,750,000 in cash and roll $1,250,000. The platform has $20 million of EBITDA, an enterprise value of $200 million and $100 million of debt, so its equity is worth $100 million and you own 1.25 percent. Five years later it has borrowed more to buy agencies and carries $130 million of debt when it is sold.
| Scenario at the platform's sale | Platform EBITDA and multiple | Equity after $130M debt | Your 1.25% | Your total proceeds |
|---|---|---|---|---|
| Upside | $35M at 12x = $420M | $290M | $3,625,000 | $7,375,000 |
| Base | $28M at 10x = $280M | $150M | $1,875,000 | $5,625,000 |
| Downside | $20M at 8x = $160M | $30M | $375,000 | $4,125,000 |
| Wipeout | $16M at 8x = $128M | $0 | $0 | $3,750,000 |
What the numbers show
Against $5,000,000 all cash, the rollover earns $2,375,000 more in the upside case and $625,000 more in the base case. In the downside case the platform's value falls 20 percent, from $200 million to $160 million, but your stake falls 70 percent, from $1,250,000 to $375,000, because the $130 million of debt is paid first. Three risks sit behind that math: debt ahead of you, a minority position with no vote on how the platform is run, and no control over when, or whether, it is sold.
Which buyer fits your goal
Most owners have two goals that pull against each other. Rank them before you meet buyers, so a strong first offer does not decide for you.
| Your main goal | Best fit | Why | Watch for |
|---|---|---|---|
| Retire fully and quickly | Public strategic or regional operator | Cash at closing and a short transition | Earnouts that need you to stay to collect |
| Stay and grow | PE-backed platform | A leadership role, capital for new locations, and equity in the result | Employment terms that cost you your equity if you leave |
| Protect staff and brand | Platform entering your state, or a regional operator | It needs your team and local name to operate there | Promises that are not written into the purchase agreement |
| Maximize total value | PE-backed platform with rollover | Rolled equity is valued at the platform's exit multiple | Platform debt and a junior class of equity |
| Maximize cash now | Strategic with overlap in your market | It can pay out of the savings from merging operations | Deep integration and a shorter role for you |
Questions to ask each buyer before you engage
Ask these before you share your full financials. A buyer that answers them plainly and offers references is usually one worth meeting.
Owner checklist
- How many agencies have you acquired, and how many are fully on your EMR, scheduling and payroll today?
- What happened to the office staff, administrator and brand at your last three acquisitions?
- Will my administrator and clinical manager have offers before closing, and on what terms?
- Who is your equity sponsor, when did it buy the platform, and how old is the fund?
- When do you expect the platform to be sold, and who would likely buy it?
- How much debt does the platform carry, and does my rollover sit in the same class as the sponsor's equity?
- Is your financing committed, or does it depend on lenders or investors you have not yet signed?
- May I speak with two owners who sold to you, including one who has since left?
How Lartico Capital fits in
Lartico Capital introduces you to screened buyers one at a time. You decide which ones to talk to, and your name is shared only after you approve a buyer and it signs an NDA. That lets you put a strategic's cash offer next to a platform's cash-plus-rollover offer before you commit to either. Lartico Capital is free for owners, and it is not a broker or an advisor, so pair it with your own attorney and CPA.
Sources and methodology
Public transactions provide market context, not a valuation quote for a private practice. Illustrative examples use hypothetical assumptions and are not predictions. This guide is educational and is not legal, tax, accounting, or investment advice.
- 1. Most Active Buyers in the Home Health and Hospice Sector (LevinPro HC). 110 deals in 2025, about 37% involving PE or portfolio companies, strategic and regional operators the majority, focus on tuck-ins, Help at Home with four deals.
- 2. Valuation Multiples from Smaller Home Health and Hospice M&A Transactions (Scope Research). 4.7x median EBITDA multiple for home-based care deals under $10M enterprise value.
- 3. Addus HomeCare acquisition of Gentiva personal care (announcement) (Addus HomeCare, SEC filing). About $350M price, about $280M annualized revenue, seven states.
- 4. Addus HomeCare pro forma financial information (Gentiva closing) (Addus HomeCare, SEC filing). Closed December 2, 2024; $350M cash; equity and asset purchase; $233M revolver draw, balance sheet cash and stock offering proceeds.
- 5. Aveanna completes acquisition of Family First Homecare (Aveanna Healthcare, SEC filing). Completed June 2026; $175.5M cash from cash on hand; 27 locations in 7 states; pediatric private duty nursing.
- 6. Amedisys completes sale to UnitedHealth Group's Optum (Paul, Weiss). $101 per share cash, about $3.3B, 164 locations in 19 states divested after a DOJ settlement.
- 7. Pennant Group completes $146M acquisition of Amedisys, UnitedHealth Group assets (Hospice News). $146.5M, 54 locations in Tennessee, Georgia and Alabama.
- 8. Pennant Group Form 10-K for 2024 (Pennant Group, SEC filing). Operations run by local clinical and operational leaders; Service Center provides accounting, payroll, HR, IT and legal.
- 9. BrightSpring's purchase of Amedisys, LHC Group locations to become accretive in 2026 (Hospice News). BrightSpring to retain all employees; CEO on applying some of its payer contracts, IT and people practices.
- 10. Havencrest announces formation of non-medical home care platform (PR Newswire). Avid Health at Home formed in 2023 with one Chicago-area agency, For Papa's Sake Home Care.
- 11. Avid Health at Home completes 8th acquisition (Havencrest Capital Management). Tech Medical Home Care Services, Kentucky and Ohio, eighth tuck-in, August 2026.
- 12. Centerbridge Partners, The Vistria Group acquire Wellspring's Help at Home (Home Health Care News). Wellspring owned since 2015, kept a minority stake; 155 locations in 13 states.
- 13. The Vistria Group, Centerbridge Partners reportedly weighing Help at Home sale (Home Health Care News). Reported possible valuation of $3 billion or more, December 2023.
- 14. General Atlantic acquires home care provider TEAM Services for $3B (Home Health Care News). About $3B including debt, about 10x EBITDA, per Bloomberg; seller Alpine Investors.
- 15. Enhabit completes acquisition by Kinderhook Industries (Enhabit, SEC filing). Completed May 15, 2026; $13.80 per share cash; delisted from the NYSE.
Reviewed November 2026
Questions owners ask
Straight answers, before you commit to anything.
Is a PE-backed platform a strategic buyer or a financial buyer?+
Both. It operates home care like a strategic and can integrate your back office, but its owner is a fund that plans to sell the whole company, which is why it offers rollover and why you should ask who the sponsor is and how long it has owned the platform.
Do strategic buyers ever offer rollover equity?+
Rarely. Public companies such as Addus, Aveanna and Pennant pay cash from their balance sheets and credit lines. A privately held strategic may offer equity, but without a planned sale it can be hard to turn into cash.
What happens to my rollover if the platform is sold to a public company?+
Your stake is normally sold alongside the sponsor's under drag-along terms and paid out after debt and any preferred equity. Your agency then goes through a second integration under the new owner.
Are private equity buyers harder on staff than strategics?+
Not by default. Both need your caregivers, and both consolidate back office roles. The bigger difference is between a buyer already in your market, which has duplicate jobs to cut, and one entering it, which needs your team to run it.
Can I talk to both types of buyer at the same time?+
Yes, and you should. Seeing a cash offer from a strategic next to a cash-plus-rollover offer from a platform is the only way to know what the rollover is really costing or earning you.
Related resources
Home care resources
- How Lartico Capital works with home care agency owners
- Sell your home care agency
- How to sell a home care agency, step by step
- Home care agency valuation
- Who buys home care agencies
- Should you sell your home care agency?
- How to sell your agency confidentially
- What to do with an unsolicited offer
- What buyers look for in a home care business for sale
- Sell a non-medical home care agency
- Sell a private duty nursing agency
- Sell a hospice agency
- Sell a pediatric home care agency
- Sell an I/DD and HCBS waiver services agency
- Sell an in-home therapy agency
Keep reading
Who buys agencies
Who acquires home care, home health, and hospice agencies in the US: private equity platforms, strategics, family offices, and local operators.
Rollover equity guide
How rollover equity works when you sell a home care, home health, or hospice agency: typical percentages, a worked example, tax basics, and key terms.
Compare offers
Compare offers for your home care agency on cash at closing, not headline price: a three-offer worked example, earnout and rollover math, buyer questions.
Confidential inquiry
Tell us about your agency.
Everything you send stays between us. We never list or shop an agency, and nothing goes to a buyer without your explicit approval. There is no cost to you at any stage.